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Brazil is a large complex country that is undergoing rapid economic, social, and environmental change. In this Series
of six articles, we have reported important improvements in health status and life expectancy, which can be ascribed
largely to progress in social determinants of health and to implementation of a comprehensive national health system
with strong social participation. Many challenges remain, however. Socioeconomic and regional disparities are still
unacceptably large, reﬂecting the fact that much progress is still needed to improve basic living conditions for a large
proportion of the population. New health problems arise as a result of urbanisation and social and environmental
change, and some old health issues remain unabated. Administration of a complex, decentralised public-health
system, in which a large share of services is contracted out to the private sector, together with many private insurance
providers, inevitably causes conﬂict and contradiction. The challenge is ultimately political, and we conclude with a
call for action that requires continuous engagement by Brazilian society as a whole in securing the right to health for
all Brazilian people.

Introduction
“Brazil is not for beginners”, said Tom Jobim, one of the
world’s greatest popular composers of the 20th century.
Throughout this Series of articles,1–5 we have shown that
this statement indeed seems to be the case. We have
reported remarkable progress in some aspects of health
and health care, in sharp contrast with stagnation or even
deterioration in other indicators. One of the ten largest
economies globally, Brazil still has a long way to go before
reaching current levels of health in the world’s most
aﬄuent nations.
Large countries tend to be complex and diﬃcult to
administrate. With nearly 200 million inhabitants, striking
regional diﬀerences exist in Brazil, from the rich southeast
and south (where life expectancy approaches that of rich
countries),1 to the poorer north and northeast, and to the
rapidly expanding frontier of the centre-west. In this Series
of articles we have shown that, despite these deep divisions,
the health of Brazilian people is improving.1–5 Over the
past four decades, life expectancy at birth increased by
more than 6 months per calendar year.1 Likewise, good
progress is being made towards most of the Millennium
Development Goals (MDGs; table 1). Indicators for MDG 1
(poverty and child undernutrition) and MDG 4 (child
survival) will most probably be met.2 Maternal mortality
trends (MDG 5) have proven diﬃcult to measure with
precision because of enhanced reporting; modelled
estimates show an annual rate of decline of around 4%,7,8
which will be insuﬃcient to reach the goal.2 With respect
to infectious diseases (MDG 6), Brazil excels in control
of vaccine-preventable diseases and HIV/AIDS, but
other diseases—particularly dengue fever—have been
unaﬀected by control eﬀorts.3
Neither chronic diseases nor violence and injuries are
part of the MDGs, although some researchers argue they

should have been included.9,10 Brazil is making some
progress in these areas. Mortality rates of noncommunicable diseases declined 20% between 1996
and 2007, mainly due to reductions in cardiovascular and
chronic respiratory diseases, in parallel with falling
smoking rates. By contrast, hypertension, obesity, and
diabetes have risen, and neuropsychiatric disorders are
currently the major contributor to disease burden.4 Both
homicide and traﬃc-related death rates started to fall
slowly after reaching peak levels in the 1990s, but much
still needs to be done to control these two epidemics;5 for
example, homicide rates in Brazil remain several fold
higher than in neighbouring countries such as Argentina,
Chile, or Uruguay.11
Social, ethnic, and regional inequalities have plagued
Brazilian society for centuries, which is not surprising
since Brazil is one of the world’s leaders in terms of income
inequalities. Nevertheless, in this Series we have provided
evidence that socioeconomic and regional gaps in several
health indicators are being narrowed progressively.
To place Brazil in perspective, table 2 shows time trends
in key socioeconomic and health indicators in the seven
Latin American countries with a population greater than
15 million inhabitants. In 1960, Brazil was ranked ﬁrst or
second in terms of poverty, income concentration, rural
population, illiteracy, and mortality. Income concentration
in Brazil is especially high, with the Gini coeﬃcient
reaching a peak of 0·64 in the late 1980s, when Brazil was
the world’s most unequal country. Unlike any other
country in table 2, Brazil has a huge land area and a major
tropical disease burden at baseline. All countries showed
progress in all indicators. Absolute and relative gaps
between Brazil and the average value of the other six
countries were reduced for all indicators, and for some of
these (fertility and urbanisation) reversals took place. Gaps
www.thelancet.com Vol 377 June 11, 2011
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Progress in terms of MDG indicators

Forecast

Eradicate extreme poverty and hunger
(reduce extreme poverty and
underweight by half; MDG 1)

Extreme poverty reduced from 8·8% (1990) to 4·2% (2005); underweight prevalence in children
younger than 5 years reduced from 5·6% (1989) to 2·2% (2006–07)

Extreme poverty reduction goal reached;
underweight reduction goal achieved

Achieve universal primary education
(MDG 2)

95% of children and adolescents aged 7–17 years enrolled in school (2008)

On track

Promote gender equality and empower
women (MDG 3)

More girls than boys are enrolled in primary, secondary, and higher education; discrimination
against women in terms of employment, income, and political representation persists

Gender equality in education goal reached; other
types of discrimination against women remain

Reduce under-5 mortality by two-thirds
(MDG 4)

Under-5 mortality falling by 4·8% a year since 1990 (MDG requires annual rate of decline of 4·2%)

On track: goal likely to be met in 2011

Reduce maternal mortality by
three-quarters (MDG 5)

Improved reporting of maternal deaths makes trends diﬃcult to estimate but reduction unlikely to Insuﬃcient progress
meet the goal; modelled estimates suggest annual reductions of 4%, lower than the rate of 5·4%
required to meet the goal

Combat HIV, AIDS, malaria, tuberculosis, Low prevalence (<0·5%) of HIV, which has been stable since 2000; almost complete eradication of
and other diseases (MDG 6)
some vaccine-preventable diseases (polio, measles, and diphtheria), diarrhoea, and Chagas’
disease; partial success in control of malaria, hepatitis A and B, tuberculosis, and schistosomiasis;
failure to control dengue and visceral leishmaniasis

Striking or partial progress against most
infectious diseases

MDG=Millennium Development Goal. Data taken from United Nations Development Programme (UNDP) Brazil, the World Bank,6 and previous articles in this Series.1–5

Table 1: Progress in MDGs achieved by Brazil

Population
(millions)

GDP per head (US$)

Gini coeﬃcient for
income concentration

Urbanisation
(%)

Adult literacy
(%)

Total fertility rate
(children/woman)

Life expectancy
at birth (years)

Under-5 mortality
rate (per 1000)

1960

1980–82

1960

2008

1960

2008

1984–87

2005–07

2007

1960

2009

1960

2009

1960

Brazil

71·7

191·9

1448

4448

0·58

0·55

45

86

75

90

6·2

1·8

54·5

72·7

178

21

Argentina

20·6

40·7

5237

9894

0·45

0·50

74

92

94

98

3·1

2·2

65·2

75·5

72

14

Chile

2008

2009

7·6

16·4

1842

6212

0·56

0·52

68

88

91

97

5·6

1·9

57·0

78·7

139

9

Colombia

16·0

44·9

1130

2986

..

0·58

45

75

..

93

6·8

2·4

56·7

73·2

144

19

Mexico

38·6

110·0

2554

6591

0·46

0·48

51

77

83

93

6·8

2·2

57·1

76·5

137

17

Peru

9·9

29·0

1647

2921

0·46

0·50

47

71

82

90

6·9

2·5

47·7

73·5

233

21

Venezuela

7·6

26·4

5425

5964

0·54

0·43

62

93

85

95

6·6

2·5

59·5

74·0

83

18

Mean*

..

..

2973

5761

0·493

0·503

57·6

82·8

86·9

94·1

6·0

2·3

57·2

75·2

134·5

16·2

Diﬀerence†

..

..

–1524

–1314

0·088

0·047

–12·7

2·8

–12·3

–4·1

0·2

–0·5

–2·7

–2·5

43·2

4·4

Ratio‡

..

..

1·18

1·09

0·49

0·77

0·78

1·03

0·86

0·96

1·04

0·80

0·95

0·97

1·32

1·27

GDP=gross domestic product. *Mean value of the indicator in the six countries (Brazil not included). †Diﬀerence between Brazil and the mean value of the other six countries. ‡Ratio between Brazil and the mean
value of the other six countries. Data taken from Gapminder.

Table 2: Evolution of selected demographic, socioeconomic, and health indicators in the seven largest countries in Latin America, 1960–2009

in terms of life expectancy and under-5 mortality were
small, except for a large reduction in the absolute gap in
under-5 mortality, from 43·2 to 4·4 deaths per
1000 livebirths between 1960 and 2009.
Trends in the health status of the Brazilian population
over the past 50 years must be interpreted in terms of
social determinants of health. Military dictatorship
from 1964 to the late 1980s was characterised by rapid
economic growth and increased income concentration,
inadequate social protection with a fragmented health
system, and little social participation in all sectors,
including health. This situation did not preclude growth
of a strong social movement advocating for reform of the
health sector in the 1970s and 1980s. The return to
democracy allowed creation of the Uniﬁed Health System
(SUS) in the new 1988 constitution, with strong popular
participation at all levels.1 Throughout this period,
changes were seen in other determinants of health,
www.thelancet.com Vol 377 June 11, 2011

including urbanisation (more than four in every ﬁve
Brazilian people now live in cities), fertility (which
dropped from more than six to fewer than two children
per woman in 40 years), and education (primary education
now being nearly universal).
From the mid-1990s, other major changes started to
happen. Hyperinﬂation was controlled and economic
stability—followed by moderate economic growth—was
established. The Family Health Strategy (formerly called
the Family Health Programme) expanded primary
health care and used geographic targeting to reach the
poorest areas of the country, particularly the rural
northeast and north, small cities, and periurban
neighbourhoods in metropolitan areas. Conditional
cash transfer programmes evolved into the current
social protection system (the Bolsa Familia), which now
beneﬁts a quarter of the population. The minimum
wage increased from US$50 (about R$83 at the 1990

For more on UNDP Brazil see
http://www.pnud.org.br/odm
For the Gapminder data see
http://www.gapminder.org/data
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exchange rate) a month in the 1980s to $300 at present
(almost R$500), and after a long period of income
concentration, the Gini coeﬃcient started to decline
from around the year 2000.
In addition to positive changes in social determinants
of health, Brazil has also proﬁted from a strong and
committed health-sector reform movement, including
not only academics, policy makers, and managers but
also health workers from all levels (eg, auxillary staﬀ,
nurses, and doctors), trade unionists, and the general
population. This social movement was at the forefront of
resistance to the post-welfare neoliberal agenda that
swept through the world in the 1980s and 1990s.1 Even
when national governments included coalitions led by
centrist or right-centrist parties, progressive health
policies continued to be pursued. A comprehensive taxbased universal health system was created at the same
time that basic packages and user fees were implemented
in the public sector in most low-income and middleincome countries.
Internationally, Brazil adopted an independent and
outspoken stance in forums such as the World Trade
Organization, at which unfair drug patent laws were
challenged.12 At WHO, Brazil expressed strong opposition
to the year 2000 World Health Report on health systems
performance. Some people might argue that Brazil’s
reaction was attributable to its poor ranking among the
world’s countries, but the critique to that report was
scientiﬁcally based, published in a high-impact journal,13
and later endorsed by the World Health Assembly.14
Nevertheless, progress has been uneven. Here, we
address some of the main achievements and remaining
challenges for the health of Brazilian people.

What is special about health in Brazil?
The Uniﬁed Health System
Since 1989, all Brazilian people have been entitled to free
health care at primary, secondary, and tertiary level
through a national health system that is unique in
Latin America, being funded by taxes and social
contributions, such as social security payments.1 As
described in the ﬁrst report of this Series,1 implementation
of the SUS was accompanied by strong decentralisation
and resulted in increased access to primary health care
through the Family Health Strategy. This change has led
to major increases in coverage,1,2 with recorded eﬀects on
infant,15,16 and possibly adult,17 mortality, and reductions
in unnecessary admissions.18 Brazil has been investing in
a sustainable system based on primary health care at a
time when many countries opted for selective primary
care and for less equitable forms of funding.19 A 2008
survey showed that 93% of Brazilian people who sought
health care were able to obtain it,1 and several interventions
for maternal and child health are now close to reaching
universal coverage, being delivered through the primary
health-care structure rather than as independent
vertical programmes.2
2044

Social participation
Intense social participation has been a cornerstone of the
SUS since the bottom-up movements that resulted in
Brazilian health-sector reform in the 1970s and 1980s.
Social participation in health was institutionalised by
the 1988 constitution and regulated further in 1990
legislation, establishing national health councils and
conferences at three levels of government: Brazil has one
national, 27 state, and more than 5500 municipal health
councils.1,20 These are permanent bodies in charge of
formulating health strategies, controlling implementation
of policies, and analysing health plans and management
reports submitted by their respective level of government.
Strong interactions exist between councils, managers,
and policy makers, forming a complex and innovative
decision-making process.1 All councils are made up of
users (50% of members), health workers (25%), and
health managers and service providers (25%). Health
conferences are held every 4 years at the three levels,
which entail many representatives with the same
proportionate distribution as the councils. The mandate
of these conferences is to assess the health situation and
propose directives for health policies, thus contributing to
inclusion of themes in the public agenda. Among other
democratic mechanisms, the participatory budget adopted
by several states and municipalities is quite innovative. A
proportion of the health budget for a city (municipality)
or state is deﬁned on the basis of popular vote; the
population of a given city can vote, for example, on
whether a new intensive-care unit or more health posts
should be built. Despite these advances, the participatory
process needs to be improved continuously.21 Social and
educational diﬀerences between users, professionals, and
managers sometimes preclude democratic dialogue on
equal terms. Corporate interests (see Dangers of
professional interests) frequently play a part, and technobureaucratic dominance could restrict the ability of
councils to make substantial changes. As a response to
these shortcomings, the National Policy for Strategic and
Participatory Management (known as ParticipaSUS) was
approved in 2007 with the clear objective to integrate
actions related to social participation, ombudsmanship,
auditing, monitoring, and evaluation. Despite some
diﬃculties, institutionalisation of social participation at
all levels is a unique characteristic of the SUS.22

Human resources for health
Qualiﬁed individuals are needed to run this complex
Brazilian health system. In 2007, 1·7 doctors, 0·9 nurses,
and 1·2 dentists were available per 1000 population, and
these people were mostly located in the southeast and
south of the country.1 Rapid growth has taken place in
terms of university enrolments for these professions:
in 2008, 90 000 medical, 220 000 nursing, and
50 000 dentistry students were in training.23 In particular,
training of nurses has been promoted to address the
chronic imbalance between nurses and doctors. Even in
www.thelancet.com Vol 377 June 11, 2011
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terms of numbers of doctors, Brazil is outperformed by
Argentina (3·2 per 1000) and Mexico (2·9 per 1000).24
The Brazilian ministries of health and education are
investing heavily to increase the focus of undergraduate
programmes on primary health care. The latest innovation is undergraduate courses devoted to training of
public-health (rather than clinical) workers.25 In parallel,
large programmes were set up to train auxiliary health
personnel, not only for the primary-care system but also
for other levels of care. Although health workers already
represent about 10% of the Brazilian workforce, several
challenges remain: uneven regional distribution of
qualiﬁed personnel, high turnover, scarcity of structured
careers, and major diﬀerences in salaries between
regions, states, and municipalities, factors which are
discussed below (see Human resources challenges).1

The public–private mix
Brazil has substantial experience to share with respect to
public–private partnerships, particularly in terms of
provision of health services. The interface between the
two sectors has evolved over time, yet it remains a
constant source of conﬂict and contradictions.1 Many
private services (non-proﬁt and for-proﬁt hospitals,
diagnostic laboratories, private outpatient clinics, etc)
provide services for both the SUS and patients with
private insurance. These facilities sometimes oﬀer a
dual standard of care according to how much they are
being reimbursed per patient. A short visit to most
private hospitals will show striking diﬀerences between
crowded wards occupied by SUS patients and comfortable
accommodation for those with private insurance. The
public–private mix also leads to distortions in use of
procedures, according to how much the government will
reimburse private providers for a speciﬁc intervention.
For example, the sharp rise in number of caesarean
sections can be traced to higher payments for operative
than for normal deliveries by social security schemes
(which predated the SUS) to private providers in
the 1970s.26 Currently, private providers systematically
complain that the values they receive from the SUS are
insuﬃcient to provide an adequate standard of care, but
on the other hand they would not be able to survive
economically without SUS contributions, which account
for more than two-thirds of their clientele. Advocates for
the SUS, in turn, argue that increased coverage and
funding from the government, coupled with strong
regulation and auditing, are essential to confer equal
status to SUS and private patients and for eﬀective
insertion of the private sector into rationalised
regionalised health-care networks. Public-private interactions are complicated further because many patients
are entitled to use both systems, and doctors, nurses,
and other health workers tend to have more than one
job, typically being employed by both sectors. In short,
the complex dimensions of the public–private mix in the
Brazilian health sector are yet to be addressed.
www.thelancet.com Vol 377 June 11, 2011

Private health insurance
Important changes are also happening in the private
insurance sector. Although Brazil has more than
1000 health plan providers,27 most of these are small and
operate at local level; among the largest companies with
national operations, fusions and acquisitions have taken
place that are rapidly leading to concentration in this
sector.28 The number of Brazilians with private insurance
rose by more than 6 million from 2002 to 2008, although
the proportion of the population covered has remained at
around 20–25%.1 As many formerly poor families join
the middle class, the clientele for new mega-companies
is likely to grow.1 There is concern, however, that the
overall price of insurance is increasing well above
inﬂation rates, and that new plans exclude disorders for
which treatment is likely to be costly. Because of the
universal nature of the SUS, private patients with
complex conditions that are not covered by their
insurance plans still rely on the public sector, even
though their private insurance contributions are largely
tax-deductible—a highly regressive policy that undermines funding for the SUS.29 Although progress has
been made in regulation of private insurance, a
redeﬁnition of the roles of this sector vis-à-vis the SUS is
essential, and stronger regulation is vital to deﬁne how to
minimise competition between public and private sectors
and how to reimburse the SUS when patients with
private insurance use public services.

Capacity building for health research
Scientiﬁc research is growing rapidly in Brazil.30 The
National Science and Technology System was launched
ﬁve decades ago with incentives for scientiﬁc training at
undergraduate and postgraduate levels. Currently, there
are 2718 postgraduate courses in the area of health,
including 55 that oﬀer masters and doctoral degrees in
public health and related ﬁelds.31 Special incentives are
provided for consolidated programmes, most of which
are in the southeast and south of the country, to foster
development of emerging groups in the rest of the
country. Publications by Brazilian researchers in peerreviewed science journals have leapt from 14 237 in 2003
to 30 415 in 2008.30 2·7% of global scientiﬁc publications
in all areas of research are from Brazil, and this proportion
is advancing faster than comparable countries in public
health sciences (ﬁgure). This growth is attributable largely
to a striking increase in government investment in
research, including grants and performance-based
funding of individual researchers and academic departments, and to investments that ensure open access to
major Brazilian journals and improve their quality. In
particular, the ministry of health established, in 2000, its
department of science and technology, which uses 1·5%
of the large SUS budget to ﬁnance health research
according to a set of priorities32 delineated after a broad
consultative process. From 2003 to 2009, the department ﬁnanced 3700 projects with a total budget of
2045
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US$400 million (more than R$907 million at 2009
exchange rates).33 Funding of postgraduate programmes
on topics such as surveillance, environmental health,
hospital management, and technological assessment,
among many others, is also supported. Academic
institutions receive funding from the ministry of health
to oﬀer these courses regularly to health managers
employed by the SUS. A major player in this area since
1979 has been the Brazilian Association of Post-Graduate
Programmes in Collective Health (ABRASCO), which
had a major role in creation of the SUS and which now
represents the academic public health community in
several national and international forums.34

A complex system such as the SUS requires a strong
regulatory body. The National Agency for Health
Surveillance (ANVISA; the Brazilian equivalent of the
US Food and Drug Administration) was set up in 1999 as
an autonomous body to regulate on a broad range of
matters: medicines and health technologies, environment,
food, health services, and frontiers.36 Eﬃcient action in
many diﬀerent areas is proving to be a major challenge,
as exempliﬁed by control of drugs. High treatment
coverage for key infections such as HIV/AIDS,
tuberculosis, and leprosy has been achieved, with
exclusive distribution of free drugs through the SUS on
the basis of protocols derived through expert consensus.
Although emergence of strains resistant to antimicrobials
remains a great concern, levels of primary and secondary
resistance have been low and stable, suggesting that
regulation has contributed to rational drug use.3 The
situation for other antimicrobials is rather diﬀerent.
Despite strong regulatory rulings, most antibiotics have
historically been available to anyone who requested them
from unlicensed salespersons in private pharmacies;37
such practices undoubtedly contributed to high levels of
antimicrobial resistance in patients with communityacquired urinary infections38 and gonorrhoea.39 At the
end of 2010, new legislation was passed to prohibit sales
of antibiotics without a medical prescription, but whether
it will be enforced eﬀectively throughout the country
remains to be seen.

Mass media and health promotion

Commercial advertising

Another positive aspect of Brazilian public health is
heavy involvement of the mass media. Televised soap
operas are an integral part of Brazilian culture and are a
major export item to other countries. Since the 1980s,
serials and other television programmes have been used
intensively by government and international organisations
and by civil society to promote healthy behaviours,
including oral rehydration for diarrhoea, breastfeeding,
condom use for HIV prevention, and family planning. In
parallel to the explicit dissemination of health messages,
the lifestyle portrayed in soap operas—eg, small families35
and leisure-time physical activity—has contributed to
shaping behavioural norms. Television and soap operas
are only one of many media channels used to promote
healthy behaviours. Local radio stations, usually operated
by community volunteers, have long had a role in health
promotion; a good example is the dissemination of
materials prepared by the Brazilian ministry of health
and UNICEF during vertical campaigns in the 1980s for
child-survival interventions. On the negative side, mass
media has been used heavily to advertise unhealthy foods

Infant foods, tobacco, alcoholic beverages, and sugared
soft drinks are examples of products with potential
harmful eﬀects on health that can be controlled through
legislation. Brazil has a mixed track record in this area.
Experience with breastmilk substitutes is highly
positive;2 infant formula and bottles cannot be advertised
to the general public, and labels of all commercial milk
products must mention that they are unsuitable to
replace breastmilk. Marketing techniques—such as
discounts and gifts—are forbidden in the case of infant
formula and bottles. Funding of scientiﬁc meetings by
infant formula companies is strictly regulated, and
grants to health personnel are not allowed. The
International Code of Marketing of Breastmilk
Substitutes was adopted in 1988 and is enforced strongly
by the Brazilian ministry of health, in collaboration with
the International Baby Food Action Network. Marketing
regulations on tobacco are also comprehensive and
strict; since 2000, advertising was prohibited, and
photographs alerting about risks are mandatory on
cigarette packets.4 By contrast, limits on the marketing
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Figure: Number of scientiﬁc articles published per year in the area of public health, in selected countries
Data taken from ABRASCO.

For ABRASCO see http://www.
abrasco.org.br

For the International Baby
Food Action Network see
http://www.ibfan.org.br
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of alcoholic beverages are weak and are restricted to
drinks with more than 13% alcohol. This constraint
allows large marketing campaigns for beer targeted at
young consumers, including sponsorship of major
sports and cultural events.4 Regulatory attempts by
ANVISA have been defeated repeatedly by industry and
the media. The situation is even more important for
energy-dense, nutrient-poor processed foods, which are
not subject to any type of regulation, not even
advertisements directed at children and adolescents.
The timid pledges voluntarily assumed in Europe and
North America by transnational food and beverages
companies are not honoured in Brazil, and repeated
attempts by ANVISA to regulate such marketing have
been blocked by industrial lobbyists.40 Unlike the
observation for breastmilk substitutes and tobacco, civil
society movements have yet to tackle the aggressive
commercial promotion of alcoholic beverages and
unhealthy processed foods, possibly because the health
hazards of moderate alcohol intake and of processed
foods are less well documented and publicised than are
those of tobacco or infant formula, both nationally and
globally. Therefore, unsurprisingly, breastfeeding is on
the increase2 and smoking is becoming less frequent;4
by contrast however, no detectable improvements have
been seen in drinking of alcohol or being overweight.4

Major challenges remain
In a large and complex country such as Brazil, to lay out
a comprehensive list of challenges to population health—
and in particular, to provision of health care—would be
overambitious. Nevertheless, some of the most important
issues that need to be tackled in the near future are
discussed below. These challenges are by no means the
only ones. A major need exists to improve coordination
between the public and private sectors, between diﬀerent
government sectors, and between diverse levels of
government—municipal, state, and federal. Furthermore,
impact assessment is crucial. Many programmes,
projects, policies, and other initiatives have been launched
in the past 20 years, the eﬀect of which are unknown
because of sparse attention to rigorous evaluation.

Reaching the hardest to reach
Despite high overall coverage and narrowing of regional
and social disparities, important health inequities
remain. Child mortality rates are still twice as high in
the north and northeast of Brazil than in the south or
southeast of the country.2 Indigenous populations,
mostly in the Amazon region, account for less than
1% of the population but still lag well behind the rest of
the country in health indicators.41 Inequalities in ethnic
groups persist for many indicators, whether in maternal
and child health, chronic diseases, or violence.2,4,5,42
Quilombolas—or communities established in the
19th century by runaway slaves—present unacceptable
levels of maternal and child health, as do settlements for
www.thelancet.com Vol 377 June 11, 2011

landless families (located throughout Brazil).43 Having
ensured high levels of access to health services for most
of the population,1 reduction of social exclusion of
speciﬁc subgroups remains a challenge to the SUS.
Further expansion and consolidation of primary care
through the Family Health Strategy can help to address
this challenge, together with the need to increase access
to secondary and tertiary care.

Financing of the SUS
The SUS has been less successful than originally expected
with respect to expansion of the share of the public sector
relative to total health expenditure, which at 41% in 2007
compares unfavourably to countries with (UK, 82%) or
without (Mexico, 47%) a national health service.1
Expenditure in private insurance and out-of-pocket
payments rose steadily over time, but the SUS has been
underfunded since its creation, despite speciﬁc funding
recommendations embedded in the 1988 constitution. The
share of the health sector in the federal budget has
remained stable, and total health expenditure represents
8·4% of the gross domestic product.44 Important constraints
exist in infrastructure, supply of specialised services, and
human resources within the SUS, which have exacerbated
the dependence of the SUS on purchasing services from
the private sector, particularly for secondary and tertiary
care. For example, only a third of all hospital beds used by
SUS patients are in public hospitals. Private providers, on
the other hand, are constantly arguing that current levels
of reimbursement by the SUS barely allow them to meet
costs. The current ﬁnancing crisis is a major threat to the
future of the SUS and a key priority for the future.

Improving quality of care
In this Series, we have not only reported striking
improvements in access to services and in coverage levels
for most health interventions but also highlighted that
the quality of services provided through the SUS is
sometimes below par—eg, in antenatal care.2 Poor quality
of care is related to institutional issues, such as high
turnover of health workers in the Family Health Strategy,
and diﬃculties in attracting skilled doctors to remote
areas despite high salaries. Such posts are mostly
attractive to young doctors who come out of medical
school and choose to postpone their further education, at
least for a few years. Greater investment in short training
courses in speciﬁc areas, such as Integrated Management
of Childhood Illnesses (IMCI)45 or syndromic management of sexually transmitted diseases,46 could
contribute to improvement of quality of care, particularly
in settings in which laboratory services are limited. Other
important threats to quality of care include: health-careassociated acquired infections (a major problem, with
hospital infection-control programmes being understaﬀed
and without a focus on surveillance); the undue eﬀect of
medical technology on clinical decision making (Brazil
has one of the highest rates of caesarean section in the
2047
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Frequency and trends
Health of mothers and children2
Illegal abortions

Highly prevalent*

Maternal mortality

Slow decline*

Preterm delivery

Increasing

Over-medicalisation of childbirth (caesarean sections, etc)

Increasing

Infectious diseases3
Dengue fever

Repeated epidemics, out of control

Visceral leishmaniasis

Increasing

Non-communicable diseases4
Overweight/obesity

Rapid increase

Diabetes

Increasing

Hypertension

High prevalence, still increasing

Psychiatric diseases

High prevalence*

Asthma

High prevalence*

Cancers of the breast, lung, prostate, and colon

Increasing

Tobacco use

Declining but still at unacceptable levels

Excessive use of alcohol

High prevalence*

The judiciary and health

External causes5
Homicides

Slight decline but still at epidemic levels

Traﬃc-related injuries and deaths

Slight decline but still at epidemic levels

Domestic violence

High prevalence*

*Reliable and representative data for time trends are not available.

Table 3: Diseases and health problems that need special attention

world);2 the reduced proportion of services that have
undergone accreditation (despite introduction of this
process in the 1990s); and scant continuity of care.47

Human resources challenges
Legislation that regulates hiring of civil servants in Brazil
is rigid. Workers can only be selected through an open
competitive process that takes several months, salary
overheads are substantial, and to dismiss under-performers
is very diﬃcult. For these reasons, doctors, nurses, and
community health workers are employed by the Family
Health Strategy through special contracts, which makes
them much easier to hire and to dismiss and allows
payment in some categories (such as doctors or nurses) of
competitive salaries that are well above those received by
other similarly qualiﬁed health workers. This plan also
allows remote municipalities to oﬀer high salaries to attract
professionals who would not otherwise be willing to live in
such areas. The downside is that family health workers
have neither a career structure nor job security or fringe
beneﬁts that other civil servants are entitled to. As a result,
job satisfaction is typically below par and staﬀ turnover is
high,48,49 leading to discontinuities in patients’ care.

Dangers of professional interests
Corporatism is a challenge to public health in Brazil.
Medical societies have lobbied strongly against allowing
other health workers—even university-trained nurses,
physiotherapists, or audiologists —to prescribe any type
2048

of drug, and this action resulted in the Law of Medical Acts
being passed by congress in 2009. Training of nurses or
community health workers in the IMCI programme,
which entails prescription of simple antibiotics to
children with suspected pneumonia, was interrupted
in 2002 because of pressure from medical societies, even
though no doctors are working in 455 of Brazil’s
5562 municipalities50 and despite strong evidence that
community case-management can reduce under-5
mortality51 and that IMCI-trained Brazilian nurses treat
common illnesses to the same standard as doctors.52 This
type of corporatism is especially paradoxical in a country
where, until new legislation was passed in late 2010,
antibiotics could be purchased easily over the counter.
Other examples include pressures exerted by doctors
against allowing nurse-midwives to deliver babies and by
registered nurses against community health workers
precluding them from administering injections.

Interference of the judicial system in prescription of
drugs is a unique occurrence in Brazil. The
1988 constitution states that “health is the duty of the
state”; patients who have been prescribed expensive,
sometimes experimental, drugs that are not part of the
essential drug lists ask judges to issue court orders
obliging municipal health managers to purchase these
drugs or to provide elective medical procedures
immediately. Managers who do not comply are
threatened with imprisonment. In 2008, the State of
Rio Grande do Sul spent 22% of its drug budget to
comply with 19 000 court orders.53 Analysis of injunctions
in São Paulo city shows that most cases were ﬁled
through private attorneys, that 47% of prescriptions were
by private doctors, and three-quarters of such patients
lived in high-income neighbourhoods.54 Interference by
the judiciary violates the key equity principle of the SUS,
by privileging individuals with higher purchasing power
and more access to information, boycotting rational
prescribing practices, and taking resources away from
priority areas. As a reaction to this stalemate, members
of parliament are proposing the elaboration of clinical
guidelines—similar to those issued by the UK’s National
Institute for Health and Clinical Excellence—to increase
the powers of health managers in ruling which
treatments and procedures are cost eﬀective.

Reducing dependency on imported health technologies
Augmented demand for public services, combined with
the rapid process of innovation and adoption of such
advances in the health system, led to a striking increase in
the proportion of the national health budget dedicated to
medical equipment and commodities (drugs, diagnostics,
vaccines, etc)—from 5·8% in 2003 to 12·3% in 2009.
These items are mostly imported and represent a growing
share of the country’s trade balance. The ministries of
health and of science and technology are making renewed
www.thelancet.com Vol 377 June 11, 2011
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investments towards reduction of such dependency, but
greater eﬀorts are needed. Brazil’s major investment in
scientiﬁc training provides a strong basis for public-private
partnerships with national entrepreneurs. Mechanisms
such as tax exemptions, low-interest loans, and market
guarantees for products produced locally are being trialled,
and further investments in this area are needed.55,56

Lessening the outcomes of environment and
climate change
The eﬀect of global climate change on disease patterns is
unquestionable.57 Vast areas of Brazil’s north (Amazon
rainforest) and centre-west (the Pantanal wetlands and
savannah) are at especially high risk owing to a
combination of overexploitation, deforestation, previous

Panel: Call for action
For a large and complex country undergoing rapid change, a
call for action towards improvement of health conditions and
provision of health services must be necessarily long. We have
divided our recommendations into categories directed at the
Brazilian Government and at other actors in the health arena.
The state has a central role in the health sector, but other
actors must also be involved to achieve the best
population health.
The Brazilian Government
We urge the Brazilian Government to reaﬃrm its commitment
to improve the health of all Brazilian people, in particular to
the 1988 constitution and SUS, by taking action in the
following areas.
Health conditions
• Expand activities aimed at achieving optimum health for
all Brazilian people, including health conditions covered
by the MDGs (health of children and mothers,
undernutrition, selected infectious diseases including HIV,
tuberculosis, and malaria) and other major health
problems (non-communicable diseases and their risk
factors, remaining infectious diseases, violence, traumas
and injuries, etc).
• Renew eﬀorts to further reduce diseases and conditions
that are still highly prevalent, including traﬃc-related
injuries and deaths, homicides, depression and other
psychiatric diseases, and use of tobacco, alcohol, and
illicit drugs.
• Prioritise diseases and conditions that are increasing in
frequency, including overweight and obesity, diabetes,
dengue fever, and prematurity, among others.
• Continue to invest in improvement of public health
surveillance, birth and death information systems
(particularly for maternal mortality), interpersonal violence,
and other currently under-reported conditions.
• Enhance actions to further reduce regional, ethnic group,
and socioeconomic inequalities in health, and particularly to
reach populations that still have insuﬃcient coverage of
health care, including Indigenous groups, landless peasants,
and quilombolas (Afro-Brazilian settlements).
• Improve use of health information technology and health
information systems.
• Ensure that monitoring and evaluation systems take equity
into account, by producing disaggregated results according to
socioeconomic status and ethnic origin.

Financing of health care
• Reverse the trend of diminishing participation of public
funds in total health expenditure by substantially increasing
the public budget for health and reducing public subsidies
for the private sector.
• Reduce the dependence of SUS on services purchased from
the private sector, particularly in-hospital care and
diagnostic services, by expanding public investment in
infrastructure.
Primary health care
• Promote and integrate the Family Health Strategy to all
levels of care as the means for reaching universal coverage
with health interventions.
• Continue to support programmes in which Brazil currently
excels, including immunisations, HIV/AIDS, and control of
endemic diseases such as Chagas disease.
Regulation, accountability, and quality of care
• Promote initiatives to improve quality of care and patients’
safety in health care.
• Monitor quality of care at all levels, including systematic and
regular auditing of deaths and near-misses associated with
preventable conditions.
• Enforce regulatory measures to avoid distortions and
over-medicalisation associated with the need to purchase a
large proportion of services from the private sector and with
scant performance monitoring of public services.
• Reinforce social participation in the health sector and take
proactive actions to ensure that existing health councils
remain representative and able to eﬀectively inﬂuence
policy at all levels.
• Ensure increased accountability of policy makers, managers,
and health personnel at all levels by strengthening
performance measurement and participatory structures,
and by establishing a strong organisational culture
orientated around quality and safety.
• Strengthen regulatory bodies to implement eﬀective
certiﬁcation processes for health workers.
• Expand existing regulations on the advertising of infant
foods and tobacco, to also cover other potentially unhealthy
products such as sugared soft drinks and alcoholic beverages.
• Strengthen regulatory bodies to produce measures that are
more eﬀective for protection of the environment and
workplaces, and for reduction of potential harmful eﬀects of
food and medicines.
(Continues on next page)
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(Continued from previous page)
Human resources for health
• Review civil-service regulations to improve the beneﬁts and
working conditions for doctors, nurses, and community
health workers employed by the Family Health Strategy, to
avoid turnover and maintain morale.
• Renew eﬀorts to address health-worker shortages in
hard-to-reach areas, by expanding on-the-job training and
promoting task-shifting of procedures from doctors to
nurses and community health workers.
• Create mechanisms for minimisation of discontinuities in
the management of SUS at municipal, state, and federal
levels as a result of political party interests.
Health research
• Continue to expand the funding available for health
research, with special emphasis on achievement of
technological independence and on thorough evaluation of
existing technologies, programmes, and services.
• Consider creating a series of research institutes similar to
the National Institutes of Health in the USA, or the UK’s
Medical Research Council.
Intersectoral actions
• Continue to promote conditional cash transfers and real
increases in the minimum wage, which have contributed
to income redistribution and near-elimination of
extreme poverty.
• Enhance social policies and programmes focused on
education, housing and social security as a means to
reduce inequities.
Health workers
We urge health workers to:
• Fully engage in the continued process of construction and
improvement of SUS.
• Participate as key actors in the process of delivering
high-coverage quality and comprehensive care to the
whole population.
• Avoid allowing narrow corporate interests to prevent
essential health interventions from reaching those who
need them most.
• Collaborate in augmenting access to high quality of care to
those living in remote areas of the country where doctors
and nurses are still not accessible.
Private sector
We urge the private sector to:
• Recognise its social role in providing services in coordination
with SUS when requested, and to fully engage in the pursuit
of high-quality health care for all Brazilian people.
• Harmonise its own ﬁnancial requirements with the
greater goal of achieving the best possible outcome for
all, by ensuring equal treatment standards to private and
SUS patients.
• Treat all patients with an equal standard of care, irrespective
of how services are being reimbursed.
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Universities, training institutions, health councils,
and researchers
We urge universities, training institutions, health councils, and
researchers to:
• Restate their commitment to SUS, speciﬁcally, to primary
health care as gatekeeper of the system and as a means of
achieving comprehensiveness in care and equity.
• Restate their commitment to train professionals to provide
high quality of care.
• Review training programmes to ensure a high supply of
family doctors and specialists directed at the public sector,
by contrast with the current focus towards production of
specialists aimed at the private sector.
• Invest further in training of public-health professionals at
the undergraduate level.
• Ensure that every graduating doctor and nurse has the basic
skills required to provide high quality of care in the Family
Health Strategy, independently of whether or not they will
become specialists in the future.
• Accelerate production of nurses and mid-level health
workers.
• Increase investment in short in-service courses directed at
doctors, nurses, and other health workers employed by SUS
and the Family Health Strategy.
• Continue to undertake research aimed at improvement of
equity in health, including monitoring and evaluation of
access and eﬀectiveness of health care, patients’
satisfaction, cost-eﬀectiveness of technologies and
interventions, development of clinical guidelines, and
health information technology.
• Expand research eﬀorts towards achievement of
technological self-suﬃciency in health products
(drugs, vaccines, diagnostics, and equipment) and
health-technology assessments.
• Expand research eﬀorts to improve knowledge and
political and public awareness about social determinants
of health.
Civil society
We urge civil society to:
• Restate its engagement in, and support for, the sanitary
reform movement and, in particular, SUS and the Family
Health Strategy.
• Continue to participate in health conferences and councils
on equal terms with health workers and government
representatives.
• Help the public sector to improve availability and quality of
services by denouncing ill-treatment, scant access, and
under-the-table payment requests.
• Understand that the best health care is not necessarily
associated with the most advanced technologies.
• Continue to have a key critical and constructive role in
building a uniﬁed, eﬀective, and equitable national
health system.
SUS=Uniﬁed Health System. MDG=Millennium Development Goal.
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environmental degradation (eg, mercury poisoning in the
major Amazon basins because of rustic open-air mining
activities),58 a local economy that is heavily dependent on
non-renewable sources of energy (eg, forest chopping and
burning), and the complex interplay of local and global
climate changes.59 Progressive environmental degradation
at the border of pristine forests, new settlements, and
large urban areas undergoing fast and chaotic development
has been associated with the urbanisation of malaria.60,61
In Brazil’s south, repeated severe ﬂooding and
tornadoes—unheard of until recent times—caused major
material damage and some loss of life together with
outbreaks of diarrhoea and leptospirosis, which were
rapidly controlled by the health sector. Although
attribution of recent increases in dengue fever and
leishmaniasis to global warming is tempting, more
complex determinants exist, including disordered
urbanisation, inadequate sanitation and garbage disposal,
and deﬁciencies in surveillance and control actions.3 The
social environment is also aﬀected by change: widespread
urbanisation and urban violence5 limit opportunities for
physical activity in public spaces; increased availability of
processed foods contributes to being overweight;40 and
rapid changes in fertility and family structures might lead
to positive and negative changes in physical and mental
disease patterns.62 Particular attention should be paid to
integrated initiatives with several beneﬁts—eg, reduction
in deforestation for production of charcoal with a
concomitant fall in periurban malaria, or promotion of
active commuting, which will increase physical activity
and reduce emissions.63

Tackling problems in health that are on the increase
In this Series, we have highlighted several health
disorders that are either increasing in prevalence or are
stable at unacceptably high levels (table 3).1–5 A crosscutting issue is the sharp growth in the elderly population,1
who are at high risk of many of these conditions,
particularly non-communicable diseases. Health issues
related to ageing were discussed by Schmidt and
colleagues.4 Improving the training of doctors and nurses
employed by the Family Health Strategy in chronic
conditions is a key challenge.

Concluding remarks
On the basis of present analyses and the preceding
articles in this Series,1–5 we conclude with a call for action
(panel), in which we specify challenges directed to the
government, private sector, academics, health workers,
and civil society as a whole. We stress, however, that the
actions recommended and the respective actors involved
are deeply interconnected, and coordinated action is
required by all.
Here, we have recorded important improvements in
health status. The core message from this Series is that
health improvements can be ascribed to favourable
changes in social determinants of health, together with a
www.thelancet.com Vol 377 June 11, 2011

strong reform movement dating from the 1970s that led
Brazil to take the unique approach—as far as Latin
America is concerned—of creating a national health
service speciﬁcally aimed at reduction of inequalities in
health. Health-sector reform and the resultant creation of
the SUS were part of a broad movement aimed at
lowering social exclusion through initiatives in health,
education, cash transfers, and other sectorial actions.64
Yet, many challenges remain. Despite overall progress,
socioeconomic and regional disparities remain unacceptably large, reﬂecting the fact that much eﬀort is still needed
to improve basic living conditions for much of the
population. New health issues arise as a result of
urbanisation and social and environmental change, and
some old health problems remain unabated. Administration of a complex, decentralised public health system—
in which a large share of services are contracted to the
private sector—inevitably causes conﬂict and contradiction,
as does the presence of a strong private health insurance
sector. The challenge is ultimately political,1 requiring
continuous engagement by Brazilian society as a whole to
secure the right to health for all Brazilian people.
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